Minimal Residual Disease in Acute Lymphoblastic Leukemia

1 Vues
administrator
administrator
06/15/23

The panelists, Raoul Tibes, MD, PhD; Stefan Faderl, MD; and Bijal D. Shah, MD, outline methods of measuring minimal residual disease and its role in the management of acute lymphoblastic leukemia.

  • Catégorie

Montre plus

Aucun commentaire trouvé

Commentaires de Facebook

Suivant